Sarah Boyce
Net Worth

Last updated:

What is Sarah Boyce net worth?

The estimated net worth of Ms. Sarah Boyce is at least $37,016,671 as of 18 Dec 2024. She owns shares worth $11,705,389 as insider, has earned $22,842,012 from insider trading and has received compensation worth at least $2,469,270 in Avidity Biosciences, Inc..

What is the salary of Sarah Boyce?

Ms. Sarah Boyce salary is $823,090 per year as Pres, Chief Executive Officer & Director in Avidity Biosciences, Inc..

How old is Sarah Boyce?

Ms. Sarah Boyce is 53 years old, born in 1972.

What stocks does Sarah Boyce currently own?

As insider, Ms. Sarah Boyce owns shares in one company:

Company Title Shares Price per share Total value
Avidity Biosciences, Inc. (RNA) Pres, Chief Executive Officer & Director 265,308 $44.12 $11,705,389

What does Avidity Biosciences, Inc. do?

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

RNA logo
RNA
Avidity Biosciences, Inc.
$44.12

Sarah Boyce insider trading

Avidity Biosciences, Inc.

Ms. Sarah Boyce has made 20 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently she sold 31,855 units of RNA stock worth $1,040,384 on 18 Dec 2024.

The largest trade she's ever made was exercising 164,233 units of RNA stock on 13 Jun 2024. As of 18 Dec 2024 she still owns at least 265,308 units of RNA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 31,855 $32.66 $1,040,384
Sale
Common Stock 32,880 $44 $1,446,720
Option
Common Stock 28,000 $1.24 $34,720
Option
Stock Option (Right to Buy) 28,000 $1.24 $34,720
Sale
Common Stock 28,000 $43.35 $1,213,828
Sale
Common Stock 28,000 $39.93 $1,118,096
Option
Stock Option (Right to Buy) 28,000 $1.24 $34,720
Option
Common Stock 28,000 $1.24 $34,720
Sale
Common Stock 32,074 $39.13 $1,255,056
Option
Stock Option (Right to Buy) 35,767 $1.24 $44,351
Option
Common Stock 35,767 $1.24 $44,351
Sale
Common Stock 35,767 $40.08 $1,433,470
Sale
Common Stock 164,233 $40.08 $6,581,802
Option
Common Stock 164,233 $1.24 $203,649
Option
Stock Option (Right to Buy) 164,233 $1.24 $203,649
Option
Common Stock 28,000 $1.24 $34,720
Sale
Common Stock 28,000 $27.42 $767,788
Option
Stock Option (Right to Buy) 28,000 $1.24 $34,720
Sale
Common Stock 28,000 $25.54 $715,064
Option
Common Stock 28,000 $1.24 $34,720
Option
Stock Option (Right to Buy) 28,000 $1.24 $34,720
Sale
Common Stock 28,000 $26.25 $734,916
Option
Stock Option (Right to Buy) 28,000 $1.24 $34,720
Option
Common Stock 28,000 $1.24 $34,720
Option
Stock Option (Right to Buy) 28,000 $1.24 $34,720
Option
Common Stock 28,000 $1.24 $34,720
Sale
Common Stock 28,000 $22.63 $633,696
Option
Common Stock 84,000 $1.24 $104,160
Option
Stock Option (Right to Buy) 84,000 $1.24 $104,160
Sale
Common Stock 84,000 $21.39 $1,796,676
Option
Stock Option (Right to Buy) 84,000 $1.24 $104,160
Sale
Common Stock 84,000 $20.14 $1,691,340
Option
Common Stock 84,000 $1.24 $104,160
Sale
Common Stock 5,092 $10.13 $51,582
Option
Common Stock 3,221 $1.24 $3,994
Option
Stock Option (Right to 3,221 $1.24 $3,994
Sale
Common Stock 3,221 $24.26 $78,141
Option
Stock Option (Right to Buy) 45,879 $1.24 $56,890
Option
Common Stock 45,879 $1.24 $56,890
Sale
Common Stock 45,879 $24.36 $1,117,750
Sale
Common Stock 900 $24.27 $21,845
Option
Stock Option (Right to Buy) 900 $1.24 $1,116
Option
Common Stock 900 $1.24 $1,116
Option
Stock Option (Right to Buy) 14,855 $1.24 $18,420
Sale
Common Stock 14,855 $23.07 $342,690
Option
Common Stock 14,855 $1.24 $18,420
Sale
Common Stock 35,045 $22.8 $798,921
Option
Common Stock 35,045 $1.24 $43,456
Option
Stock Option (Right to Buy) 35,045 $1.24 $43,456
Option
Common Stock 100 $1.24 $124
Sale
Common Stock 100 $22.47 $2,247
Option
Stock Option (Right to Buy) 100 $1.24 $124

Avidity Biosciences key executives

Avidity Biosciences, Inc. executives and other stock owners filed with the SEC: